Thursday, May 11, 2017

United Arab Emirates (UAE) Market Research Reports: Ken Research

Positioned as an important economy of Middle East, The United Arab Emirates (UAE) represents seven emirates including Abu Dhabi, Ajman, Dubai, and Fujairah, Ras al-Khaimah, Sharjah and Umm al-Quwain. President and Vice President Selections are based on Federal Supreme Council. UAE is known for its oil reserves where it stands on 7th place in World ranking also in natural gas reserves country holds 17th place in worldwide ranking.
UAE Market Research Reports
In Gulf Council, UAE economy is known to be most diversified with its strongest country Dubai which is acknowledged for its business worldwide and trade of petroleum and natural gas. In GCC region, UAE falls on second place considering largest economy with GDP of USD 370 billion in 2015.
GDP Composition by End Use
Particulars                                             Percentage (%)
Household Consumption                    61.1%
Government Consumption                 9.3%
Investment in Fixed Capital                29.7%
Investment in Inventories                   0.7%
Exports of Goods and Services           81.5%
Imports of Goods and Services           -82.3%
Source: CIA World face book
UAE economy has a major dependence on petroleum and natural gas with almost 80% of the revenue comes from oil exports. Dubai which is considered as business hub is one of the known tourist destination which act as a driving force to the economy of the country. Dubai tourism attracts various investment opportunities and has given boost to the real restate and hospitality sectors.
Reports tags
UAE Market Share
UAE Market Trends
UAE Market Future Outlook
UAE Market Research Reports
UAE Market Research Company
UAE Market Report Segmentations
UAE Market Size Research Reports
UAE Industry Competition Analysis
UAE Market Growth Reports
UAE Market Import Export Scenario
UAE Market Competitive Landscape
UAE Industry Developments
UAE Market Growth Reports
UAE Market Analysis Research Reports
Timeline of UAE Growth
2
For more coverage click on the link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
Posted by at No comments:
Labels: , , , , , ,

Urbanization and immigration to boost residential construction of Norway: Ken research

Norway is a sovereign and unitary monarchy situated in the western portion of the Scandinavian Peninsula. Its economy is a mixed economy with state ownership in the strategic areas. The economy is driven primarily by abundance of natural resources, including petroleum exploration and production, hydroelectric power, and fisheries. Albeit the state holds control over most of the major industries, its economy is quite open and has a high ranking on ease of doing business index. The service sector dominates the economy, closely followed by the manufacturing sector. Norway even though is not a part of EU but is a part of its single market i.e. EEA. 
Norway Construction Industry Research Report
The nation is known for its very high standard of living and well integrated social welfare system. It has the sixth highest GDP (PPP) per capita in the world and ranks second in terms of wealth in monetary value. Norway also sees one of the highest hourly wage rate and productivity level. Further, the public healthcare is almost free. All the citizens have access to safe drinking water and most of them have access to proper sanitation facility. Thus, the nation has consecutively topped the Human Development index. The nation is said to be the most well functioning and stable country in the world.
Ken Research, a market research firm says, Norway is not a densely populated nation albeit has the highest fertility rate in Europe. The immigration is high and is responsible for majority of the population growth. The unemployment rate is notably lower than the global average and majority of the citizen live in urban areas. The country is comparatively peaceful and has a very low rate of homicide. The nation is also amongst the best educated countries.
However, recently due to fall in the prices of global oil prices has jolted the economy. The interest rate is going down and the currency has deprecated, this has led to fall in the consumer confidence as the people are saving more and spending less on big ticket items. 
Research report titles “Residential Construction in Norway to 2020: Market Forecast” says, Norway construction industry is set to expand in the upcoming years as the government invests in the transport infrastructure. Government is planning to launch a series of infrastructure projects under fourth National Transport Plan (NTP) 2014-2023. The rising population, rapid urbanization and low unemployment will support the market. The market will further be driven by the introduction of new technologies in infrastructure and construction industry However, the sector will face certain risks due to the increasing labor and construction costs, relatively weak economic growth picture, slow down in spending on oil infrastructure
In the 1950s the residential infrastructure construction market was driven by the high population growth in Norway but currently it is ruled by high net immigration. In 2014, the highest share in the construction industry was with the residential construction. One of the major challenges for this industry is presence of a big number of unoccupied dwellings and housing stock losses. Geographical factors impact the demand for housing all over the nation, as net internal migration increases the need for housing the central areas also rise.
Key Topics Covered in the Report:
Norway Construction Industry Research Report
Norway Residential Construction Market
New Residential Projects Norway
Norway Construction Market Players
Norway Infrastructure Industry Trends
Norway Residential Construction Sector
Norway Real Estate Industry
Norway Construction Industry Future Outlook
For more coverage click on the link below:
Related links:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
Posted by at No comments:
Labels: , , , ,

Government regulations to help personal indemnity and D&O insurance market of UK : Ken Research

The UK has a low mortality and birth rate which implies like all the other developed nations it has a slow population growth. The nation has almost cent percent literacy rate and this is attributed to universal public education system introduced in 1870 . The number of people above 65 years is significantly high. Majority of the people live in the urban areas but the rate of urbanization currently is steady. The net immigration rate  is very high and this was one of the major reasons for Brexit.




The biggest factor that is said to influence UK’s economy is the Brexit vote. However , contrary to popular predictions that UK economy would be in a deep trouble after the Brexit vote , the growth of the nation has been slow as before. It is not that it has been completely unaffected by the referendum. As the value of pound Sterling fell , the fiscal deficit has risen. The sudden drop in the value of pound has given rise to many complications. Ken Research in its analysis says, the import costs have shot up and doing global business has become expensive. This vote also led to a tiff between tesco and its biggest supplier, Unilever . Unilever  wanted to increase prices in the UK to compensate for drop in value. This led Tesco to temporarily stopping sale of its most famous brands - including Marmite - to online shoppers.
Research report titled “Professional Indemnity and D&O Insurance in the UK-Key Trends and Opportunities to 2020” says, insurance in the United Kingdom is divided into various categories. The categorisation put in sections 333B, and 431B to 431F of the Income and Corporation Taxes Act 1988(ICTA) and  each category of business given a different tax treatment. TheFinancial Services Authority was formed in 2001 as the regulator. In 2013 theFinancial Services Authoritywas dissolvedandFinancial ConductAuthority and Prudential Regulation Authority were given responsibility of financial conduct.
Professional indemnity and Directors and Office insurance is needed to protect professionals and businesses when claim made by third party. It protects an individual when made against  him/herfor alleged wrongful acts in their capacity as a Director or Officer or against the organisation. Claims can be made either by shareholders or creditors however recently a growing incidence of claims being made against Directors & Officers by regulatory bodies. It also covers the legal and other costs and expenses incurred in the defence of a claim. Professional Indemnity Insurance and Directors & Officers Insurance operate on the basis of “claims made basis” I.e.  policy comes in force at the time the claim is notified which will operate irrespective of  when the alleged act of professional negligence or wrongful act took place or when the work was actually undertaken
The UK PI and D&O market has shown a constant growth since 2012, however this market is one of the least concentrated market. The UK market for personal indemnity is consolidated as five of the firms account for more than half the market share. The main drivers of this market is trends in business population and confidence , directors rising public exposure and increase in the regulatory activity.
Topics Covered in the Report
  • UK Insurance Regulatory Framework
  • Global insurance sector
  • UK insurance industry trends
  • UK professional indemnity and D&O insurance market
  • UK Professional Indemnity Insurance Penetration
  • UK Professional Indemnity Gross Written Premium
  • UK Insurance industry Regulations
  • UK Insurance industry research report
  • UK Non-life insurance market research
  • UK Professional Indemnity Insurance market Growth
  • UK Professional Indemnity Insurance market future
  • UK Professional Indemnity Insurance market Trends
  • UK Professional Indemnity Insurance market analysis
  • UK Commercial Liability Insurance Premiums and PI Share
  • UK Professional Indemnity Insurance-Gross Written Premium
  • UK Professional Indemnity Insurance-Penetration and Density
For more coverage click on the link below:
https://www.kenresearch.com/banking-financial-services-and-insurance/insurance/professional-indemnity-d-o-insurance-uk-key-trends/80402-93.html
Related links:
https://www.kenresearch.com/banking-financial-services-and-insurance/insurance/household-insurance-uk-key-trends/80400-93.html
https://www.kenresearch.com/banking-financial-services-and-insurance/insurance/personal-accident-health-insurance-uk-key-trends-opportunities-2019/4239-93.html
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249
Posted by at No comments:
Labels: , , , ,
Location: Europe

Wednesday, May 10, 2017

Myelodysplastic Syndrome-Pipeline Review, H2 2016: Ken Research

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome-Pipeline Review, H2 2016, provides an overview of the Myelodysplastic Syndrome (Oncology) pipeline landscape.
Myelodysplastic syndrome (MDS) is a condition that affects the bone marrow and the blood cells it produces. Myelodysplastic syndromes rarely cause signs or symptoms in the early stages of the disease. Symptoms include fatigue, shortness of breath, unusual paleness (pallor) due to anemia, easy or unusual bruising or bleeding and frequent infections.
Medizin
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Myelodysplastic Syndrome-Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Myelodysplastic Syndrome (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Myelodysplastic Syndrome (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Myelodysplastic Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 11, 62, 55, 3, 13 and 2 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical, Discovery and Unknown stages comprises 6, 7, 2, 1 and 2 molecules, respectively.Myelodysplastic Syndrome.
Myelodysplastic Syndrome (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Myelodysplastic Syndrome (Oncology).
The pipeline guide reviews pipeline therapeutics for Myelodysplastic Syndrome (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Myelodysplastic Syndrome (Oncology) therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Myelodysplastic Syndrome (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Myelodysplastic Syndrome (Oncology)
Key Topics Covered in the Report:
Myelodysplastic Syndrome Products Glance
Key Players In Myelodysplastic Syndrome Therapeutics
Myelodysplastic Syndrome Market Research Report
Myelodysplastic Syndrome Market Trends
Myelodysplastic Syndrome Overview
Myelodysplastic Syndrome Market Forecast
Myelodysplastic Syndrome Future Projections
Myelodysplastic Syndrome Competition Analysis
Myelodysplastic Syndrome Competitive Landscape
For more coverage click on the link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
Posted by at No comments:
Labels: , , , ,

Nicotine Addiction-Pipeline Review, H1 2017: Ken Research

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nicotine Addiction-Pipeline Review, H1 2017, provides an overview of the Nicotine Addiction (Central Nervous System) pipeline landscape.
Nicotine addiction also called tobacco dependence is an addiction to tobacco products caused by the drug nicotine. Predisposing factors include age, depression, schizophrenia, post-traumatic stress disorder and alcoholism. Person experiences withdrawal symptoms at cessation of using, such as shaky hands, sweating, irritability, or rapid heart rate. Treatment includes nicotine replacement therapy (NRT).
nicotine addiction
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Nicotine Addiction-Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Nicotine Addiction (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Nicotine Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Nicotine Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 11 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 5 molecules, respectively.
Nicotine Addiction (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Nicotine Addiction (Central Nervous System).
The pipeline guide reviews pipeline therapeutics for Nicotine Addiction (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Nicotine Addiction (Central Nervous System) therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Nicotine Addiction (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Nicotine Addiction (Central Nervous System)
Key Topics Covered in the Report:
Nicotine Addiction Market Research Report
Nicotine Addiction Market Trends
Key Players in Nicotine Addiction Therapeutics
Global Nicotine Addiction Overview
Global Nicotine Addiction Market Forecast
Global Nicotine Addiction Future Projections
Global Nicotine Addiction Competition Analysis
Global Nicotine Addiction Customer Preference
Global Nicotine Addiction Competitive Landscape
For more coverage click on the link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
Posted by at No comments:
Labels: , , , ,

Microsensors Industry Growing Globally: Ken Research

KEN RESEARCH has recently announced latest publication on “Global Micro sensors Industry Situation and Prospects Research 2017” providing an in depth market condition of motherboards industry. It provides the basic overview of micro sensors industries and the proper market analysis of its development status regionally and the competition among the players.
Global Microsensors Technology
This report provides the information about the development policies and the plans adopted by the manufacturers with the manufacturing process and the cost indulge in it. It gives an overview about the imports/exports, supply & consumption figures, and the micro sensors revenues and gross margins.
In, micro sensors industry the investment is generally feasible for the new innovative projects making it ideal source of information for manufacturers, suppliers, distributors, customers, investors and individuals who have interest in this market. It is well equipped with the statistics to make the information more reliable.
Micro sensors are devices that detect events, or changes in quantities, and deliver a corresponding output, typically in the form of an optical or electrical signal.  These sensors are generally used to improve the functionality of the devices in which they are implemented. Micro sensors are quite popular because they are small in size and consume low power; hence enterprises are investing in this market to meet customers’ increasing demands.
World gross product is forecast to expand by 2.7 % in 2017 and 2.9% on 2018, which will stabilize the economic condition and thus giving a signal of robust and sustained revival of global demand. This provides a close linkage between the demand, investment, trade and productivity, which is extending the global growth and prove the self-perpetuating in the micro sensors industry of concerted policy efforts to revive investment and foster a recovery in the productivity.
Socially the progress is impeding towards the sustainable development goals (SDGs), particularly the goal of eradicating extreme poverty and creating decent work for all. North America region is leading micro sensors market, because of the excess use of smart devices. Asia pacific and Japan, are also turning into prominent leaders because of the of numerous sensors vendors emerging in this region.
Western Europe is expected to grow in the near future as the government is willing to invest in new technologies whereas Latin America and Middle East and Africa are expected to witness a slower growth if compared to other regions.
Micro sensors industry is definitely expected to prosper globally as in the years to proceed as it is seen to bring up the much needed enhancements and opportunities for making profits and generating revenues and local distributors are expected to play a major role in promotion of the industry.
Key Topics Covered in the Report:
Global Microsensors Industry Research
Global Microsensors Technology
Japan Microsensor Demand Analysis
China Microsensor Demand Analysis
India Microsensor Demand Analysis
Europe Microsensor Consumption Volume
North America Microsensor Consumption Volume
Global Microsensor Production Trends
Global Microsensors Industry Future Outlook
For more coverage click on the link below:
Related Reports
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
Posted by at No comments:
Labels: , , , ,
Subscribe to: Posts (Atom)